BioCentury | Oct 20, 2011
Distillery Therapeutics

Indication: Cancer

...week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Colorectal cancer Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G...
BioCentury | May 27, 2010
Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease HIV/AIDS Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G; A3G); IL-15; toll-like receptor 2 (TLR2); TLR3; TLR9 A study in rhesus macaques suggests...
Items per page:
1 - 2 of 2